I do not have access to the full content of the STAT+ article you cited. The search results provided include information on GSK's pricing measures for asthma and COPD inhalers, but not data from the specific article titled "Asthma patients suffered as GSK pursued 'egregious' price hikes, senator says". Available information shows that GSK has implemented a program to reduce the cost of the Ventolin inhaler and other respiratory drugs to $35 per month for eligible patients[1], and that the company has entered into an agreement with the US government to reduce drug prices, including the respiratory portfolio[3]. In the Czech Republic, the unavailability of Ventolin on the market was reported in connection with the pricing policy[2]. In order to create an accurate summary of the requested article, I would need access to its full text. Can you give me the content of the article or a larger part of it?